AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need.
Our small molecules have shown Proof-of-Principle in preclinical models for a range of otic disorders including hearing loss, tinnitus and electrode insertion trauma as well as Parkinson’s Disease. The safety and tolerability of AudioCure’s lead compound AC102 has been demonstrated in a first-in-human clinical trial. Currently, a Proof-of-Concept, Phase 2 clinical trial evaluating AC102’s efficacy in patients with Sudden Sensorineural Hearing Loss is underway across Europe.
Join us to make a meaningful impact on the lives of those affected by these disorders and turn incurable hearing loss into a treatable event.
Our small molecules have shown Proof-of-Principle in preclinical models for a range of otic disorders including hearing loss, tinnitus and electrode insertion trauma as well as Parkinson’s Disease. The safety and tolerability of AudioCure’s lead compound AC102 has been demonstrated in a first-in-human clinical trial. Currently, a Proof-of-Concept, Phase 2 clinical trial evaluating AC102’s efficacy in patients with Sudden Sensorineural Hearing Loss is underway across Europe.
Join us to make a meaningful impact on the lives of those affected by these disorders and turn incurable hearing loss into a treatable event.
Investors 1
| Date | Name | Website |
| - | High-Tech ... | htgf.de |
Mentions in press and media 4
| Date | Title | Description |
| 14.02.2025 | FINN secures €1B ABS financing, NXP Semiconductors acquires Kinara, and Bitpanda launches in the UK | This week we tracked more than 70 tech funding deals worth over €1.9 billion, and over 5 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most im... |
| 14.02.2025 | InfectoPharm partners with AudioCure to advance hearing loss therapy | InfectoPharm has invested in AudioCure Pharma, a Berlin-based biotech company. The main goal of the collaboration is to successfully advance the clinical development of AC102, a drug for sudden hearing loss. InfectoPharm is a family-owned G... |
| 02.01.2025 | AudioCure Pharma gewinnt Innovationspreis Berlin Brandenburg 2024 mit ihrem neuen Wirkstoff AC102 | Christin Galetzka und Dr. Alena Meis von der Firma AudioCure nehmen den Innovationspreis entgegegen. Quelle: Stefan Schubert | Agentur Medienlabor Prämierter Wirkstoff AC102 konnte im Lärmtrauma-Modell das Hörvermögen fast vollständig wiede... |
| 17.11.2023 | Will Innovative Biotech Solutions Cure Noise-induced Hearing Loss Worldwide? | Key takeaways: AudioCure Pharma, a Berlin-based biotechnology startup, is researching and developing novel therapeutics for hearing diseases and injuries. Founded by Professor Hans Rommelspacher, AudioCure’s research team is composed of wor... |